These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 39126837)

  • 1. The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells.
    Wang F; Bashiri Dezfouli A; Multhoff G
    Mol Immunol; 2024 Oct; 174():1-10. PubMed ID: 39126837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR T Cells Targeting Membrane-Bound Hsp70 on Tumor Cells Mimic Hsp70-Primed NK Cells.
    Bashiri Dezfouli A; Yazdi M; Benmebarek MR; Schwab M; Michaelides S; Miccichè A; Geerts D; Stangl S; Klapproth S; Wagner E; Kobold S; Multhoff G
    Front Immunol; 2022; 13():883694. PubMed ID: 35720311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer.
    Gunther S; Ostheimer C; Stangl S; Specht HM; Mozes P; Jesinghaus M; Vordermark D; Combs SE; Peltz F; Jung MP; Multhoff G
    Front Immunol; 2015; 6():556. PubMed ID: 26579130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
    Stangl S; Gross C; Pockley AG; Asea AA; Multhoff G
    Cell Stress Chaperones; 2008; 13(2):221-30. PubMed ID: 18759005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II Trial.
    Specht HM; Ahrens N; Blankenstein C; Duell T; Fietkau R; Gaipl US; Günther C; Gunther S; Habl G; Hautmann H; Hautmann M; Huber RM; Molls M; Offner R; Rödel C; Rödel F; Schütz M; Combs SE; Multhoff G
    Front Immunol; 2015; 6():162. PubMed ID: 25926832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells.
    Hromadnikova I; Li S; Kotlabova K; Dickinson AM
    PLoS One; 2016; 11(3):e0151535. PubMed ID: 26982331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy--a case report.
    Milani V; Stangl S; Issels R; Gehrmann M; Wagner B; Hube K; Mayr D; Hiddemann W; Molls M; Multhoff G
    J Transl Med; 2009 Jun; 7():50. PubMed ID: 19549307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.
    Hromadnikova I; Pirkova P; Sedlackova L
    Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.
    Kokowski K; Stangl S; Seier S; Hildebrandt M; Vaupel P; Multhoff G
    Strahlenther Onkol; 2019 Apr; 195(4):352-361. PubMed ID: 30747241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.
    Moser C; Schmidbauer C; Gürtler U; Gross C; Gehrmann M; Thonigs G; Pfister K; Multhoff G
    Cell Stress Chaperones; 2002 Oct; 7(4):365-73. PubMed ID: 12653481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
    Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells.
    Gross C; Schmidt-Wolf IG; Nagaraj S; Gastpar R; Ellwart J; Kunz-Schughart LA; Multhoff G
    Cell Stress Chaperones; 2003; 8(4):348-60. PubMed ID: 15115287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70-Derived Peptide: A Combined Computational and Experimental Study.
    Yazdi M; Hasanzadeh Kafshgari M; Khademi Moghadam F; Zarezade V; Oellinger R; Khosravi M; Haas S; Hoch CC; Pockley AG; Wagner E; Wollenberg B; Multhoff G; Bashiri Dezfouli A
    Adv Sci (Weinh); 2024 Apr; 11(14):e2305998. PubMed ID: 38298098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells.
    Elsner L; Flügge PF; Lozano J; Muppala V; Eiz-Vesper B; Demiroglu SY; Malzahn D; Herrmann T; Brunner E; Bickeböller H; Multhoff G; Walter L; Dressel R
    J Cell Mol Med; 2010 Apr; 14(4):992-1002. PubMed ID: 20569278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Levels of Circulating Hsp70 and an Increased Prevalence of CD94+/CD69+ NK Cells Is Predictive for Advanced Stage Non-Small Cell Lung Cancer.
    Seier S; Bashiri Dezfouli A; Lennartz P; Pockley AG; Klein H; Multhoff G
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428793
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
    Front Immunol; 2019; 10():454. PubMed ID: 30967859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70.
    Wang F; Dezfouli AB; Khosravi M; Sievert W; Stangl S; Schwab M; Wu Z; Steiger K; Ma H; Multhoff G
    Cell Death Discov; 2023 Aug; 9(1):286. PubMed ID: 37542074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
    Multhoff G; Seier S; Stangl S; Sievert W; Shevtsov M; Werner C; Pockley AG; Blankenstein C; Hildebrandt M; Offner R; Ahrens N; Kokowski K; Hautmann M; Rödel C; Fietkau R; Lubgan D; Huber R; Hautmann H; Duell T; Molls M; Specht H; Haller B; Devecka M; Sauter A; Combs SE
    Clin Cancer Res; 2020 Oct; 26(20):5368-5379. PubMed ID: 32873573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck.
    Gehrmann M; Specht HM; Bayer C; Brandstetter M; Chizzali B; Duma M; Breuninger S; Hube K; Lehnerer S; van Phi V; Sage E; Schmid TE; Sedelmayr M; Schilling D; Sievert W; Stangl S; Multhoff G
    Radiat Oncol; 2014 Jun; 9():131. PubMed ID: 24912482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time- and Dose-Dependent Effects of Ionizing Irradiation on the Membrane Expression of Hsp70 on Glioma Cells.
    Fellinger H; Stangl S; Hernandez Schnelzer A; Schwab M; Di Genio T; Pieper M; Werner C; Shevtsov M; Haller B; Multhoff G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32276468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.